Matthew J. Wood, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 1512 12th Ave Rd, Nampa, ID 83686 Phone: 208-463-5029 |
Ronald William Cornwell, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 4400 E Flamingo Ave, Ste 200, Nampa, ID 83687 Phone: 208-302-2700 Fax: 208-302-2725 |
Dennis Weiler, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3918 Chicago St, Nampa, ID 83686 Phone: 208-467-5155 |
Dr. Forrest R Fredline, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 4400 E Flamingo Ave Ste 200, Nampa, ID 83687 Phone: 208-302-2700 Fax: 208-302-2725 |
Christian P Vetsch, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-463-3141 Fax: 208-463-3044 |
Richard J Martin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4400 E Flamingo, Ste 200, Nampa, ID 83687 Phone: 208-302-2700 Fax: 208-302-2725 |
Katherine Homer, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4400 E Flamingo Ave Ste 200, Nampa, ID 83687 Phone: 208-302-2700 Fax: 208-302-2725 |
Amber Taylor, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4400 E Flamingo Ave Ste 200, Nampa, ID 83687 Phone: 208-302-2700 Fax: 208-302-2725 |
News Archive
An Alabama state court jury on Tuesday found pharmaceutical companies GlaxoSmithKline and Novartis guilty of defrauding the state Medicaid program by charging artificially high prices for medications and ordered the two companies to pay more than $114 million in restitution, the AP/Minneapolis Star Tribune reports.
Researchers have determined how the most common gene mutation in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) disrupts normal cell function, providing insight likely to advance efforts to develop targeted therapies for these brain diseases.
Eurofins Biomnis has considerably improved sample preparation productivity in its specialized clinical pathology laboratory.
Urovalve, a medical device company focused on creating products for urinary flow and control, announced today that it has received $400,000 in new funding from the National Institutes of Health (NIH) to advance development of its Surinate Bladder Management System—designed to improve the quality of life of men who suffer from acute or chronic urinary retention, an inability to empty the bladder.
› Verified 1 days ago